Manchester's 4D Pharma Reels In $29 Million

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Manchester drug development company 4d pharma has announced the conditional placing of over 14 million new shares at a price of 150p.

The placing, which was managed by investment banking boutique Zeus Capital, raises the company an additional £21.5 million.

Help employers find you! Check out all the jobs and post your resume.

Back to news